HomeInsightsResults

Sun Pharmaceuticals Industries Ltd Quarterly Result

Sun Pharmaceuticals Industries Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.1 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

Net Profit

₹ 3030.67

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Sun Pharmaceuticals Industries Ltd for the Sep '24 is ₹ 13645 crore as compare to the Jun '24 revenue of ₹ 13185 crore. This represent the growth of 3.4894152%.
  • The ebitda of Sun Pharmaceuticals Industries Ltd for the Sep '24 is ₹ 4292 crore as compare to the Jun '24 ebitda of ₹ 4140 crore. This represent the growth of 3.6904292%.
  • The net profit of Sun Pharmaceuticals Industries Ltd for the Sep '24 is ₹ 3030 crore as compare to the Jun '24 net profit of ₹ 2871 crore. This represent the growth of 5.552283%.

Results Analysis

Market Price of Sun Pharmaceuticals Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20241777.65
19 Nov 20241775.2
18 Nov 20241747.2
14 Nov 20241768.6
13 Nov 20241779.3
12 Nov 20241799.85
11 Nov 20241794.9
08 Nov 20241811.35
07 Nov 20241791.5
06 Nov 20241827.25

Historical Revenue of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Sun Pharmaceuticals Industries Ltd News Hub

News

Sun Pharma tumbles after US court halts Leqselvi launch

Aa result of the court's decision, Sun Pharma has been temporarily barred from launching L...

Read more

04 Nov 202411:14

News

Sun Pharmaceuticals Industries Ltd up for third straight session

Sun Pharmaceuticals Industries Ltd is up for a third straight session today. The stock is ...

Read more

28 Oct 202413:05

News

Sun Pharma gains after Q2 PAT climbs 28% YoY to Rs 3,040 cr

Profit before tax was at Rs 3,597.88 crore in Q2 FY25, registering a growth of 28.91% on Y...

Read more

28 Oct 202416:01

News

Sun Pharmaceuticals Industries to hold board meeting

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

09 Oct 202417:30

News

Sun Pharma inks global licensing agreement with Philogen

Sun Pharmaceutical Industries and Philogen S.p.A (Philogen) today announced that they have...

Read more

01 Oct 202410:34

News

Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun

Philogen is an Italian-Swiss company active in the biotechnology sector, specialized in th...

Read more

01 Oct 202410:34

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

July 2024

PPT

May 2024

Transcript

Mar 2024

PPT

Feb 2024

Transcript

Jan 2024

PPT

Nov 2023

Transcript

Sep 2023

PPT

May 2023

Transcript

Apr 2023

PPT

Nov 2022

Transcript

Sep 2022

PPT

Aug 2022

Transcript

June 2022

Transcript

Mar 2022

PPT

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Jan 2021

Transcript

Oct 2020

Transcript

FAQ's For Sun Pharmaceuticals Industries Ltd Quarterly Result

What is the EPS of Sun Pharmaceuticals Industries Ltd stock?

The Earnings Per Share (EPS) of Sun Pharmaceuticals Industries Ltd is 46.72. An EPS is the amount of net income attributed to each share of a common stock.

How is Sun Pharmaceuticals Industries Ltd EPS calculated?

The EPS of Sun Pharmaceuticals Industries Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sun Pharmaceuticals Industries Ltd report its EPS?

Sun Pharmaceuticals Industries Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sun Pharmaceuticals Industries Ltd EPS?

Factors that influence the EPS of Sun Pharmaceuticals Industries Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sun Pharmaceuticals Industries Ltd EPS growth indicate future performance?

Yes, consistent growth in Sun Pharmaceuticals Industries Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*